{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:25:44Z","timestamp":1789071944865,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113760","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T08:32:24Z","timestamp":1733819544000},"page":"113760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["DPP4 promotes an immunoenhancing tumor microenvironment through exhausted CD8+ T cells with activating IL13-IL13RA2 axis in papillary thyroid cancer"],"prefix":"10.1016","volume":"145","author":[{"given":"Ren","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3099-1941","authenticated-orcid":false,"given":"Shijian","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10387","key":"10.1016\/j.intimp.2024.113760_b0005","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.intimp.2024.113760_b0010","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","article-title":"National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data","volume":"8","author":"Qi","year":"2023","journal-title":"Lancet Public Health"},{"issue":"3","key":"10.1016\/j.intimp.2024.113760_b0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.intimp.2024.113760_b0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.intimp.2024.113760_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101013","article-title":"Radioiodine-refractory differentiatedthyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance","volume":"72","author":"Shen","year":"2024","journal-title":"Drug Resist. Updat."},{"issue":"6","key":"10.1016\/j.intimp.2024.113760_b0030","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/ERC-21-0414","article-title":"Translating the immune microenvironment of thyroid cancer into clinical practice","volume":"29","author":"Cunha","year":"2022","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.intimp.2024.113760_b0035","article-title":"Immune landscape of thyroid cancers: new insights","volume":"11","author":"Menicali","year":"2020","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.intimp.2024.113760_b0040","article-title":"Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2024.113760_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.851","article-title":"Mechanism of immune escape mediated by receptor tyrosine kinase KIT in thyroid cancer","volume":"11","author":"Luo","year":"2023","journal-title":"Immun Inflamm Dis."},{"issue":"13","key":"10.1016\/j.intimp.2024.113760_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133449","article-title":"Analysis of expression of programmed cell death ligand 1 (PD-L1) and BRAF (V600E) mutation in thyroid cancer","volume":"15","author":"Sekino","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.intimp.2024.113760_b0055","article-title":"Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities","volume":"1878","author":"Zhang","year":"2023","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.intimp.2024.113760_b0060","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/08820139.2023.2268656","article-title":"New insights into immune cells and immunotherapy for thyroid cancer","volume":"52","author":"Tao","year":"2023","journal-title":"Immunol. Invest."},{"issue":"10","key":"10.1016\/j.intimp.2024.113760_b0065","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/s41418-023-01217-x","article-title":"METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer","volume":"30","author":"Ning","year":"2023","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.intimp.2024.113760_b0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-020-01213-6","article-title":"Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p\/snail\/DPP4 axis","volume":"19","author":"Huang","year":"2020","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2024.113760_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030487","article-title":"DPP4 inhibitor sitagliptin enhances lymphocyte recruitment and prolongs survival in a syngeneic ovarian cancer mouse model","volume":"13","author":"Wilson","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2024.113760_b0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13046-022-02478-z","article-title":"Long noncoding RNA LINC01132 enhances immunosuppression and therapy resistance via NRF1\/DPP4 axis in hepatocellular carcinoma","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.113760_b0085","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s40618-020-01455-7","article-title":"DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway","volume":"44","author":"Hu","year":"2021","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2024.113760_b0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13148-024-01685-z","article-title":"Estrogen-mediated DNMT1 and DNMT3A recruitment by EZH2 silences miR-570-3p that contributes to papillary thyroid malignancy through DPP4","volume":"16","author":"Hu","year":"2024","journal-title":"Clin. Epigenetics"},{"issue":"5","key":"10.1016\/j.intimp.2024.113760_b0095","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13344","article-title":"Senescence-associated \u03b2-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans","volume":"20","author":"Mart\u00ednez-Zamudio","year":"2021","journal-title":"Aging Cell"},{"issue":"D1","key":"10.1016\/j.intimp.2024.113760_b0100","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.intimp.2024.113760_b0105","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"23","key":"10.1016\/j.intimp.2024.113760_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13235947","article-title":"The serine protease CD26\/DPP4 in non-transformed and malignant T cells","volume":"13","author":"Chitadze","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.intimp.2024.113760_b0115","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5489","article-title":"Effect of DPP4\/CD26 expression on SARS\u2011CoV\u20112 susceptibility, immune response, adenosine (derivatives m(6)(2)A and CD) regulations on patients with cancer and healthy individuals","volume":"62","author":"Du","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2024.113760_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155340","article-title":"Nonenzymatic function of DPP4 promotes diabetes-associated cognitive dysfunction through IGF-2R\/PKA\/SP1\/ERp29\/IP3R2 pathway-mediated impairment of Treg function and M1 microglia polarization","volume":"138","author":"Hui","year":"2023","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.intimp.2024.113760_b0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41375-020-0824-y","article-title":"A novel chimeric antigen receptor redirecting T-cell specificity towards CD26(+) cancer cells","volume":"35","author":"Zhou","year":"2021","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.intimp.2024.113760_b0130","article-title":"Dipeptidyl peptidase 4\/midline-1 axis promotes T lymphocyte motility in atherosclerosis","volume":"10","author":"Rao","year":"2023","journal-title":"Adv Sci (Weinh)."},{"issue":"11","key":"10.1016\/j.intimp.2024.113760_b0135","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1007\/s12094-023-03187-5","article-title":"Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer","volume":"25","author":"Zuo","year":"2023","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113760_b0140","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2268257","article-title":"Dipeptidyl peptidase 4 inhibition sensitizes radiotherapy by promoting T cell infiltration","volume":"12","author":"Tian","year":"2023","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.intimp.2024.113760_b0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01867-9","article-title":"Human CD26(high) T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence","volume":"8","author":"Bailey","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2024.113760_b0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/imm.12028","article-title":"CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production","volume":"138","author":"Hatano","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2024.113760_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1282653","article-title":"IFN-\u03b3 lowers tumor growth by increasing glycolysis and lactate production in a nitric oxide-dependent manner: implications for cancer immunotherapy","volume":"14","author":"Chattopadhyay","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113760_b0160","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.gendis.2023.01.027","article-title":"IL-13\/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53","volume":"11","author":"He","year":"2024","journal-title":"Genes Dis."},{"issue":"5","key":"10.1016\/j.intimp.2024.113760_b0165","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/infdis\/jiad383","article-title":"Interleukin 13-induced inflammation increases DPP4 abundance but does not enhance middle east respiratory syndrome coronavirus replication in airway epithelia","volume":"229","author":"Li","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.intimp.2024.113760_b0170","doi-asserted-by":"crossref","DOI":"10.1111\/all.15647","article-title":"IL-13, periostin and dipeptidyl-peptidase-4 reveal endotype-phenotype associations in atopic dermatitis","author":"Maintz","year":"2023","journal-title":"Allergy"},{"issue":"26","key":"10.1016\/j.intimp.2024.113760_b0175","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1182\/blood.2022017326","article-title":"IL-13\/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms","volume":"140","author":"Melo-Cardenas","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.intimp.2024.113760_b0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06255-4","article-title":"Schnurri-3 drives tumor growth and invasion in cancer cells expressing interleukin-13 receptor alpha 2","volume":"14","author":"Bartolom\u00e9","year":"2023","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.intimp.2024.113760_b0185","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1210\/jc.2019-00040","article-title":"IL13RA2 is differentially regulated in papillary thyroid carcinoma vs follicular thyroid carcinoma","volume":"104","author":"Chong","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.intimp.2024.113760_b0190","article-title":"Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer","volume":"5","author":"Bagheri","year":"2024","journal-title":"Cell Rep. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924022823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924022823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T19:42:03Z","timestamp":1734637323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924022823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":38,"alternative-id":["S1567576924022823"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113760","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DPP4 promotes an immunoenhancing tumor microenvironment through exhausted CD8+ T cells with activating IL13-IL13RA2 axis in papillary thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113760"}}